Literature DB >> 23412348

Invasive cribriform carcinoma in a Chinese population: comparison with low-grade invasive ductal carcinoma-not otherwise specified.

Wei Zhang1, Tongxian Zhang, Zhichun Lin, Xuebao Zhang, Fen Liu, Yahong Wang, Han Liu, Yiling Yang, Yun Niu.   

Abstract

Invasive cribriform carcinoma (ICC) and low-grade invasive ductal carcinoma (IDC) were recently considered to belong to a low-grade breast neoplasia family. However, none of publications has compared ICC and low-grade IDC at present. Meanwhile, in order to evaluate prognostic significance of clinicopathological characteristics of different cribriform contents in ICC and invasive breast cancer with less cribriform structures, a retrospective review of fifty-one cases of ICC and forty cases of invasive breast cancer with less cribriform pattern (less than fifty percent) was conducted in a Chinese population. Forty-nine cases of low-grade IDC without cribriform elements were selected as a control. ICC presented more favorable prognostic factors than those of invasive breast carcinoma with less cribriform pattern and low-grade IDC, such as smaller tumor size, less frequent axillary lymph node involvement, higher positive rate of estrogen receptor and/or progestogen receptor expression, and lower proliferation index. The expression of human epidermal growth factor receptor two in ICC and invasive breast cancer with less cribriform pattern was mostly negative. Pure ICC showed less frequency of axillary lymph node involvement, but not its number. The proliferation index in the pure type was lower, although the tumor size in these two types was not obviously different. Tumors contained cribriform structures had a more favorable prognosis than those with low-grade IDC. Considering the tumor biology, and the benign course of pure ICC studied, chemotherapy may not be indicated in the typical case.

Entities:  

Keywords:  China; Invasive cribriform carcinoma; breast; invasive ductal carcinoma; prognosis

Mesh:

Substances:

Year:  2013        PMID: 23412348      PMCID: PMC3563205     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  22 in total

Review 1.  Is adjuvant chemotherapy useful for women with luminal a breast cancer?

Authors:  Alan S Coates; Marco Colleoni; Aron Goldhirsch
Journal:  J Clin Oncol       Date:  2012-02-21       Impact factor: 44.544

2.  Genetic changes at specific stages of breast cancer progression detected by comparative genomic hybridization.

Authors:  Yuxia Gao; Yun Niu; Xiaowei Wang; Li Wei; Song Lu
Journal:  J Mol Med (Berl)       Date:  2008-10-21       Impact factor: 4.599

Review 3.  Adjuvant therapies for special types of breast cancer.

Authors:  Marco Colleoni; Leila Russo; Silvia Dellapasqua
Journal:  Breast       Date:  2011-10       Impact factor: 4.380

4.  Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer.

Authors:  Eitan Amir; Naomi Miller; William Geddie; Orit Freedman; Farrah Kassam; Christine Simmons; Maria Oldfield; George Dranitsaris; George Tomlinson; Andreas Laupacis; Ian F Tannock; Mark Clemons
Journal:  J Clin Oncol       Date:  2011-11-28       Impact factor: 44.544

5.  Increasing steroid hormone receptors expression defines breast cancer subtypes non responsive to preoperative chemotherapy.

Authors:  Marco Colleoni; Vincenzo Bagnardi; Nicole Rotmensz; Richard D Gelber; Giuseppe Viale; Giancarlo Pruneri; Paolo Veronesi; Rosalba Torrisi; Anna Cardillo; Emilia Montagna; Elisabetta Campagnoli; Alberto Luini; Mattia Intra; Viviana Galimberti; Eloise Scarano; Giulia Peruzzotti; Aron Goldhirsch
Journal:  Breast Cancer Res Treat       Date:  2008-10-22       Impact factor: 4.872

6.  Microarray comparative genomic hybridization analysis of tubular breast carcinoma shows recurrent loss of the CDH13 locus on 16q.

Authors:  Marc-Oliver Riener; Elisabeth Nikolopoulos; Alexander Herr; Peter Johannes Wild; Michael Hausmann; Thorsten Wiech; Marzenna Orlowska-Volk; Silke Lassmann; Axel Walch; Martin Werner
Journal:  Hum Pathol       Date:  2008-07-24       Impact factor: 3.466

7.  Tubular carcinoma of the breast: further evidence to support its excellent prognosis.

Authors:  Emad A Rakha; Andrew H S Lee; Andrew J Evans; Sindhu Menon; Nancy Y Assad; Zsolt Hodi; Douglas Macmillan; Roger W Blamey; Ian O Ellis
Journal:  J Clin Oncol       Date:  2009-11-16       Impact factor: 44.544

8.  Transcriptomic analysis of tubular carcinomas of the breast reveals similarities and differences with molecular subtype-matched ductal and lobular carcinomas.

Authors:  Maria A Lopez-Garcia; Felipe C Geyer; Rachael Natrajan; Bas Kreike; Alan Mackay; Anita Grigoriadis; Jorge S Reis-Filho; Britta Weigelt
Journal:  J Pathol       Date:  2010-09       Impact factor: 7.996

9.  Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?

Authors:  C Simmons; N Miller; W Geddie; D Gianfelice; M Oldfield; G Dranitsaris; M J Clemons
Journal:  Ann Oncol       Date:  2009-03-18       Impact factor: 32.976

10.  Morphologic and molecular evolutionary pathways of low nuclear grade invasive breast cancers and their putative precursor lesions: further evidence to support the concept of low nuclear grade breast neoplasia family.

Authors:  Tarek M A Abdel-Fatah; Desmond G Powe; Zsolt Hodi; Jorge S Reis-Filho; Andrew H S Lee; Ian O Ellis
Journal:  Am J Surg Pathol       Date:  2008-04       Impact factor: 6.394

View more
  9 in total

1.  Characteristics of Special Type Breast Tumors in Our Center.

Authors:  Tonguç Utku Yılmaz; Levent Trabzonlu; Sertaç Ata Güler; Mehmet Ali Baran; Gökhan Pösteki; Cengiz Erçin; Zafer Utkan
Journal:  Eur J Breast Health       Date:  2018-01-01

Review 2.  Rare Breast Cancer Subtypes.

Authors:  Sarah Jenkins; Megan E Kachur; Kamil Rechache; Justin M Wells; Stanley Lipkowitz
Journal:  Curr Oncol Rep       Date:  2021-03-23       Impact factor: 5.075

3.  Invasive cribriform carcinoma of the breast: A report of nine cases and a review of the literature.

Authors:  Yizi Cong; Guangdong Qiao; Haidong Zou; Jun Lin; Xingmiao Wang; Xiaohui Li; Yalun Li; Shiguang Zhu
Journal:  Oncol Lett       Date:  2015-02-17       Impact factor: 2.967

Review 4.  An Updated Review of Cribriform Carcinomas with Emphasis on Histopathological Diagnosis and Prognostic Significance.

Authors:  Giovanni Branca; Antonio Ieni; Valeria Barresi; Giovanni Tuccari; Rosario Alberto Caruso
Journal:  Oncol Rev       Date:  2017-03-10

5.  The scaffold protein p140Cap limits ERBB2-mediated breast cancer progression interfering with Rac GTPase-controlled circuitries.

Authors:  Silvia Grasso; Jennifer Chapelle; Vincenzo Salemme; Simona Aramu; Isabella Russo; Nicoletta Vitale; Ludovica Verdun di Cantogno; Katiuscia Dallaglio; Isabella Castellano; Augusto Amici; Giorgia Centonze; Nanaocha Sharma; Serena Lunardi; Sara Cabodi; Federica Cavallo; Alessia Lamolinara; Lorenzo Stramucci; Enrico Moiso; Paolo Provero; Adriana Albini; Anna Sapino; Johan Staaf; Pier Paolo Di Fiore; Giovanni Bertalot; Salvatore Pece; Daniela Tosoni; Stefano Confalonieri; Manuela Iezzi; Paola Di Stefano; Emilia Turco; Paola Defilippi
Journal:  Nat Commun       Date:  2017-03-16       Impact factor: 14.919

6.  Clinical characteristics and overall survival prognostic nomogram for invasive cribriform carcinoma of breast: a SEER population-based analysis.

Authors:  Jiameng Liu; Xiaobin Zheng; Zhonghua Han; Shunguo Lin; Hui Han; Chunsen Xu
Journal:  BMC Cancer       Date:  2021-02-16       Impact factor: 4.430

Review 7.  Histology of Luminal Breast Cancer.

Authors:  Ramona Erber; Arndt Hartmann
Journal:  Breast Care (Basel)       Date:  2020-07-15       Impact factor: 2.860

8.  Clinicopathological Characteristics and Survival Outcomes of Invasive Cribriform Carcinoma of Breast: A SEER Population-Based Study.

Authors:  Xi-Yu Liu; Yi-Zhou Jiang; Yi-Rong Liu; Wen-Jia Zuo; Zhi-Ming Shao
Journal:  Medicine (Baltimore)       Date:  2015-08       Impact factor: 1.889

9.  Invasive cribriform carcinoma of the breast detected incidentally on computed tomography: A case report.

Authors:  Yasuhiro Adachi; Takefumi Katsuki; Takakazu Sasaguri; Keiji Hirata; Naoki Nagata
Journal:  Clin Case Rep       Date:  2021-12-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.